TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $23,000 | -30.3% | 21,336 | -19.0% | 0.00% | – |
Q1 2021 | $33,000 | +3.1% | 26,335 | -44.4% | 0.00% | – |
Q4 2020 | $32,000 | +39.1% | 47,335 | +73.2% | 0.00% | – |
Q3 2020 | $23,000 | +4.5% | 27,335 | -22.6% | 0.00% | – |
Q2 2020 | $22,000 | +46.7% | 35,335 | +65.6% | 0.00% | – |
Q1 2020 | $15,000 | – | 21,335 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 432,503 | $554,000 | 0.09% |
MONECO Advisors, LLC | 35,000 | $45,000 | 0.02% |
Purus Wealth Management, LLC | 15,000 | $19,000 | 0.02% |
Renaissance Technologies | 8,454,364 | $10,822,000 | 0.01% |
LMR Partners LLP | 390,864 | $500,000 | 0.01% |
ExodusPoint Capital Management, LP | 595,459 | $762,000 | 0.01% |
LINCOLN CAPITAL CORP | 12,000 | $15,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 264,500 | $339,000 | 0.01% |
HRT FINANCIAL LP | 347,816 | $445,000 | 0.01% |
FIRST MIDWEST BANK TRUST DIVISION | 25,000 | $32,000 | 0.00% |